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Summary
Objective: To examine the capacity of recombinant osteogenic protein-1 (OP-1) to inhibit the cartilage extracellular matrix damage that
follows treatment with hyaluronan hexasaccharides (HA6).
Design: The effects of OP-1 were examined on isolated human chondrocytes grown in alginate beads as well as articular cartilage slices
treated with hyaluronan hexasaccharides. Changes in the relative expression of messenger RNA for hyaluronan synthase- 2, aggrecan and
CD44 were determined by competitive quantitative reverse transcriptase-polymerase chain reaction. Cartilage proteoglycan biosynthesis
was examined by a 35S-sulfate incorporation assay. Cell-associated matrix of human chondrocytes was visualized by the use of particle
exclusion assay, and alcian blue staining. Cartilage slices were examined for accumulation of proteoglycan by Safranin-O, and hyaluronan
by a specific biotinylated probe.
Results: Combined OP-1 and HA6 treatment resulted in enhanced expression of mRNA for aggrecan and HAS-2, compared to the treatment
with HA6 only. This increased expression of aggrecan mRNA was paralleled by an increased synthesis of cartilage proteoglycan especially
retained in the cell-associated matrix. Co-treatment with OP-1 inhibited the HA6-induced depletion of cell-associated matrices as well as
HA6-induced depletion of hyaluronan and proteoglycan within cartilage tissue slices.
Conclusions: These results demonstrate that OP-1 can abrogate the catabolic events associated with a HA6-induced matrix depletion model
of osteoarthritis. The mRNA levels of two major cartilage extracellular matrix components, aggrecan and hyaluronan synthase-2 are
enhanced above values obtained by either OP-1 or HA6 treatments alone.
© 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Osteoarthritis is a degenerative joint disease characterized
by the loss of extracellular matrix macromolecules within
articular cartilage. The most remarkable and consistent
alteration is a depletion of the aggregating cartilage
proteoglycan, aggrecan1. However, since the retention of
aggrecan within the cartilage matrix is dependent on the
presence of optimal concentrations of hyaluronan (HA) as
well as associated functional HA receptors, CD44 in par-
ticular, metabolic alterations in any one of these three
molecular components may contribute to the loss of this
proteoglycan. A significant decrease of HA has been noted
in human cartilage derived from osteoarthritis patients as
compared with normal human cartilage2. Depletion of HA
has been observed in early stages of experimental osteo-
arthritis in dogs3. Reduced joint loading due to splint
immobilization in dogs also resulted in a significant
decrease of HA in articular cartilage4. In the latter unloaded
canine cartilage model, decreased synthesis appears to be
responsible for the loss of matrix HA5,6. To test the role of
HA on the maintenance of homeostasis in articular carti-
lage, a means to affect the specific disruption of HA is
needed. We have reported that antisense inhibition of
hyaluronan synthase-2 (HAS-2), the principal enzyme
involved in HA biosynthesis in articular cartilage, caused a
depression of cell-associated matrix formation in human
articular cartilage7. Previous investigations in our groups
have also demonstrated that small HA oligosaccharides
with a minimum length of 6 monosaccharides (HA6) effec-
tively competed the binding of HA to CD448–10, resulting in
the loss of proteoglycans (PGs) and an elevation or acti-
vation of gelatinolytic activity as well as aggrecanase
activity, effectively mimicking osteoarthritic cartilage11.
Large sized HA oligosaccharides (i.e., HA with ≥10 mono-
saccharides) are equally effective in displacing CD44-
bound HA. However, these oligosaccharides have the
additional capacity to displace non-link protein-stabilized
aggrecan from HA filaments12–14. Therefore, in order to
examine the effects of the disruption of HA specifi-
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cally bound to the CD44 receptor, HA6 or HA8 should be
used.
Osteogenic protein-1 (OP-1) also known as bone mor-
phogenetic protein-7 (BMP-7) is a member of the trans-
forming growth factor- superfamily15. BMPs were
originally characterized by their capacity to induce the
formation of cartilage and bone at heterotopic sites16,17.
Other studies have demonstrated that recombinant BMP
can induce endochondral bone formation15,18 and promote
and maintain the chondrogenic phenotype19–21. The latter
was indicated by their ability to stimulate proteoglycan
synthesis in chick limb bud cell cultures, fetal rat chondro-
blasts, rabbit and bovine articular chondrocytes19–21.
Among the family of BMPs, OP-1 has been shown to
stimulate proteoglycan synthesis in cultured bovine
articular chondrocytes and porcine articular cartilage
explants22,23 in particular, the synthesis of type II collagen
and aggrecan, without inducing the synthesis of type I or
type X collagen, phenotypic markers of chondrocyte differ-
entiation24. Recently, we have demonstrated that OP-1
also stimulates HA and CD44 synthesis in addition to
aggrecan. The functional outcome of this upregulation was
an increase in the cell-associated matrix associated with
human or bovine articular chondrocytes25,26.
Among the many models attempting to mimic osteo-
arthritic cartilage, the general approach is to affect an
enhancement of cartilage catabolism. For example, with
the addition of IL-1 there is an induction of MMP activity and
an inhibition of proteoglycan synthesis27. Treatment of
cartilage tissues with trypsin28 or collagenase29 disrupts
the cartilage matrix and is followed by enhanced matrix
biosynthesis. Addition of small HA oligosaccharides (HA6)
to cartilage tissues specifically depletes the HA bound to
CD44, leading to ‘chondrocytic chondrolysis’ in spite of an
enhancement of the expression of HAS-2 and aggrecan
mRNA11. In this study, the effect of OP-1 on the matrix
depletion induced by HA oligosaccharides in human
articular chondrocytes as well as cartilage slices was
examined. HAS-2 and aggrecan mRNA expression were
stimulated by the HA6 treatment; however, OP-1 enhanced
the mRNA expression above these levels in HA6 cultures.
A 35S-sulfate incorporation approach demonstrated that
newly-synthesized proteoglycan in cell-associated matrix
was upregulated by OP-1 in HA6 treated cultures. Alcian
blue staining indicated an accumulation of cell-associated
proteoglycan in HA6 treated chondrocytes stimulated
with OP-1. This up-regulation also gave rise to prominent
increases in functional cell-associated matrices. In carti-
lage slices, Safranin-O staining revealed that the HA6-
induced proteoglycan loss could be prevented by the
addition of OP-1, together with an enhanced accumu-
lation of HA. The findings suggest that OP-1 effectively
prevents the cartilage matrix depletion in an HA6-induced
‘chondrocytic chondrolysis’ model.
Materials and methods
TISSUE ACQUISITION
Human articular cartilage from donors without known
joint disease was obtained within 24 h of death from the
‘Gift of Hope’ Organ & Tissue Donor Network (formerly the
Regional Organ Bank of Illinois), in accordance with insti-
tutional protocol and with institutional approval. The aver-
age age of the donors was 59 years ranging from 43 to 69
years of age. Noncalcified articular cartilage was dissected
from the talus of donors.
CELL CULTURE
Full thickness articular cartilage slices were dissected
under aseptic conditions and then subjected to sequential
pronase/collagenase (Calbiochem, San Diego, CA and
Boehringer Manheim, Indianapolis, IN, respectively) diges-
tion to liberate chondrocytes from the tissue as described
previously30. Isolated chondrocytes were cultured in algi-
nate (Keltone LV, 1.2% in 150 mM NaCl; Kelco, Chicago,
IL) beads as described previously31. The beads were
maintained in DMEM/Ham’s F-12 medium+5% fetal bovine
serum (FBS; Summit Biotechnology, Ft. Collins, CO) and
25 µg of ascorbate per ml for 5 days to recover. After 5 days
in culture, the chondrocytes in the alginate beads were
treated with 250 µg/ml of HA6 in the presence or absence
of 100 ng/ml recombinant human OP-1 (rHuOP-1; Stryker
Biotech, Hopkinton, MA) which was stored as a stock
solution in 50% ethanol and 0.1% trifluoroacetic acid (TFA)
at −20°C. HA6 was prepared as described previously11.
Briefly, human umbilical cord HA (Sigma, St. Louis MO)
was used to generate HA oligosaccharides by testicular
hyaluronidase cleavage. After precipitation of heat-
inactivated hyaluronidase, the oligosaccharides were dried,
dissolved in water, and further characterized by Biogel P-6
chromatography (Bio-Rad, Richmond, CA).
TISSUE CULTURE
Full thickness slices of the human articular cartilage
(∼10×10×1 mm) were cultured directly in 1.0 ml of medium
containing 10% FBS. Following 2 days of culture for recov-
ery, the tissue slices were treated in the presence of HA6
with or without OP-1 in the presence of 5% of fetal bovine
serum (FBS). The concentration of HA6 and OP-1 is
250 µg/ml and 100 ng/ml, respectively, and in the range
shown previously to elicit significant responses in cultured
chondrocytes11,25. The culture medium containing HA6
with or without OP-1 was changed every 4 days. Following
14 days of incubation the slices were removed and embed-
ded in O.C.T. embedding compound (Tissue-TekR, Electron
Microscopy Sciences, Washington, PA). Cryostat sections
(8.0 µm) were prepared and stained for Safranin-O and HA.
RNA ISOLATION
Total RNA was isolated from alginate-cultured human
chondrocytes that had been treated with or without
100 ng/ml of OP-1 in the presence of 250 µg/ml of HA6 for
5 days. Following treatment the chondrocytes were
released from alginate by treatment with 55 mM sodium
citrate in 150 mM NaCl31, followed by a digestion with
0.25% trypsin/EDTA for 10 min. The cells were then
washed once with phosphate buffered saline (PBS) and
extracted for total RNA using Trizol (Life Technologies,
Grand Island, NY) and following the manufacturer’s instruc-
tions. RNA was dissolved in diethyl pyrocarbonate-treated
H2O, and the concentration of RNA in each sample was
measured by its absorbance at 260 nm.
COMPETITIVE RT-PCR
Total cytoplasmic RNA extracted from chondrocytes with
Trizol reagents was subjected to reverse transcription and
quantitative competitive PCR. Briefly, 0.25 µg of total RNA
was converted to cDNA using Molony murine leukemia
virus reverse transcriptase in the presence of 0.15 µM
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HAS-2, CD44 or aggrecan-specific downstream primers
(HAS-2: 5′-TTT CTT TAT GTG ACT CAT CTG TCT CAC
CGG-3′, CD44: 5′-AAC CGC GAG AAT CAA AGC CAA
GGC C-3′, aggrecan: 5′-CTC CAC TGC CTG TGA AGT
CAC CAC-3′). DNA fragments that share the same primer
template sequence with the target cDNA but, contain
a completely different, smaller or larger intervening
sequence, were prepared and used as DNA internal
standards (i.e., mimics)25,32,33. Aliquots of sample cDNA
mixed together with serial dilutions of DNA mimics were
co-amplified as templates in the presence of downstream
primers and 0.15 µM upstream primers for HAS-2, CD44 or
aggrecan (HAS-2 upstream: 5′-ATT GTT GGC TAC CAG
TTT ATC CAA ACG G-3′, CD44 upstream: 5′-GAT CCA
CCC CAA TTC CAT CTG TAC-3′, aggrecan upstream:
5′-GCA CCA TGC CTT CTG CTT CCG AG-3′), in a PCR
mixture consisting of 2 mM magnesium chloride, 200 µM of
each deoxyribonucleotide, and 2.5 units of AmpliTaq DNA
polymerase. The DNA was denatured by heating at 95oC
for 2 min, followed by 23 cycles of 1 min at 95oC, annealing
at 60oC, and extension at 72oC for 1 min (Perkin Elmer
thermocycler). This reaction was followed by a final
elongation step that lasted 5 min at 72oC. The amplified
products were analyzed by electrophoresis on 1.5% agar-
ose gels followed by staining with SYBR green I. The
stained products were scanned and quantified using a
fluoroimaging system (Molecular Dynamics). The log of the
ratio of fluorescence intensity of target to mimic PCR
products was graphed as a function of the log of the
attomolar concentration of mimic added to the reaction.
When the amplified products are equimolar (including
minor corrections for differences in size), the initial concen-
tration of the target mRNA is equal to the concentration of
mimic molecules.
To determine that all samples contained equivalent
amounts of RNA (or to normalize results due to small
differences), in a separate set of reactions total RNA from
samples were co-amplified in the presence of serial
dilutions of an RNA internal standard (mimic) prepared for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
The GAPDH RNA mimic shares the same primer template
sequence but contains a smaller intervening sequence.
Samples containing 0.25 µg of sample total RNA were
co-reverse transcribed with 2-fold serial dilutions of
GAPDH RNA mimic in the presence of 0.15 µM GAPDH-
specific downstream primer (5′-TTA CTC CTT GGA GGC
CAT GTG GGC C-3′). The sample and mimic cDNA prod-
ucts were then co-amplified in the presence of the GAPDH-
specific downstream primer together with 0.15 µM
upstream primer (5′-ACT GCC ACC CAG AAG ACT GTG
GAT GG-3′) using PCR conditions as described for HAS-2
amplification.
35S-SULFATE INCORPORATION
After 5 days of 250 µg/ml of HA6 treatment with or
without 10, 50 or 100 ng/ml of OP-1, chondrocytes in
alginate beads were radiolabeled with 35S-sulfate
(20 µCi/ml; Amersham Corp, Arlington Heights, IL) for 4 h.
After 24 h of chase, the culture media were removed as the
‘medium fraction.’ The chondrocytes were then released
from alginate by treatment with 55 mM sodium citrate in
150 mM sodium chloride31, centrifuged and divided into
two parts: the pelleted fraction representing the cell-
associated matrix and supernatant fraction, the further
removed matrix27. To extract PGs from cell-associated
matrix, each fraction was treated for 24 h at 4°C with 4 M
guanidine HCl containing the following protease inhibitors
at these final concentrations: 10 mM EDTA, 0.1 M
6-aminohexanoic acid, 5 mM benzamidine hydrochloride,
10 mM N-ethylmaleimide, and 0.5 mM phenylmethylsul-
fonylfluoride34. 35S-labeled PGs in each medium and dis-
sociative extract were quantified by liquid scintillation
counting following rapid filtration, as described pre-
viously35. The 35S-PGs cpm values were normalized to
cellular DNA content35.
ALCIAN BLUE STAINING
Following treatment of alginate cultures of chondrocytes
in the presence of 250 µg/ml of HA6 with or without
100 ng/ml of OP-1 for 5 days, the beads were washed with
0.3 M MgCl2 (containing 25 mM NaAcetate, pH 5.6) and
then transferred into a staining solution (made with 20 ml
washing buffer plus 1 ml Alcian blue solution; kind gift
from Dr John Scott, University of Manchester, UK), for 2 h
at room temperature27. Following two washes the alginate
beads were placed directly onto a slide, and compressed
down with a coverslip. The whole mount preparations were
photographed under bright-field microscopy.
HYALURONAN STAINING WITH HABP
Eight µm cryostat sections of cartilage slices mounted
onto glass slides, were fixed with 2% paraformaldehyde
buffered with PBS at room temperature for 2 h. Tissue
sections were pretreated with 2 units of chondroitinase
ABC (at pH 8.0) for 2 h at 37oC for unmasking. The
tissue sections were next treated with 0.3% H2O2 in 30%
methanol for 30 min at room temperature to block the
internal peroxidase activity and then incubated with 1%
bovine serum albumin in PBS for 1 h at room temperature.
Sections were next incubated with 2.0 µg/ml of a bio-
tinylated HA binding protein (HABP) probe (Seikagaku
America, Rockville, MD) for 2 h at room temperature
followed by a streptavidin-peroxidase reagent (Vectastain
kit, Burlingame, CA) and diaminobenzidine-containing sub-
strate solution (SIGMA FASTTM DAB). As a control, tissue
sections were pretreated with 5 units/ml Streptomyces
hyaluronidase for 1 h at 60oC.
PARTICLE EXCLUSION ASSAY
Cell-associated pericellular matrices were visualized
using a particle exclusion assay9. Briefly, following
250 µg/ml of HA6 treatment of alginate cultures of chondro-
cytes with or without 100 ng/ml of OP-1 for 7 days, the
chondrocytes were released from alginate beads and
transferred to six-well, flat bottom, tissue culture plate
(Falcon), and ‘splatted’ onto the substratum by centrifuga-
tion at 500 g for 15 min in an Omifuge RT (Baxter Scientific,
McGaw Park, IL) microtiter plate holder36. The supernatant
medium was removed and replaced with a 0.75-ml suspen-
sion of formalin-fixed erythrocytes (108 per ml) in PBS
containing 0.1% bovine serum albumin. The particles were
allowed to settle for 15 min. The cells were observed and
photographed with an inverted phase-contrast microscope
with Varel optics (Zeiss, Thornwood, NY).
STATISTICAL ANALYSIS
Results of gene expression and proteoglycan synthesis
studies were expressed as the mean±SD of triplicate
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samples. Analysis was performed using student’s unpaired
2-tailed t-tests. P values less than or equal to 0.05 were
considered significant.
Results
THE EFFECT OF OP-1 ON CHONDROCYTE GENE EXPRESSION OF
AGGRECAN, HAS-2 AND CD44 IN HA6 INDUCED MATRIX DEPLETION
MODEL
Previous studies in our laboratory have shown that the
assembly of chondrocyte cell-associated matrices depend
on the presence of three components namely, aggrecan,
HA and CD447,8,37. To investigate the effects of OP-1 in a
HA6 induced matrix depletion model on the expression of
these molecules, the mRNA levels of aggrecan, HAS-2 and
CD44 were determined by quantitative competitive RT-
PCR analysis. Fig. 1A show a representative competitive
RT-PCR analysis for CD44, HAS-2 and aggrecan respect-
ively, after 5 days of culture. Absolute copy numbers of
GAPDH, CD44, HAS-2 and aggrecan in a representative
control culture were, 275 attomoles, 1.05 attomoles, 1.81
attomoles and 112 attomoles/0.25 µg of total RNA, respect-
ively. Data from three independent experiments were aver-
aged and the change in mRNA copy number due to OP-1
plus HA6 or HA6 alone versus mRNA levels in untreated
control chondrocytes was expressed as a ratio. As shown
in Fig. 1B, HAS-2 and aggrecan mRNA copy number was
up-regulated by HA6 treatment compared with untreated
control cultures (∼2-fold increase). The CD44 mRNA level
was slightly up-regulated (1.3-fold increase, P=0.48).
Addition of OP-1 to the cultures in the presence of HA6
significantly stimulated the expression of HAS-2 and
aggrecan mRNA levels compared with HA6 alone (2.2-fold
increase, P=0.046 and 2.5-fold increase, P=0.036, respect-
ively). The CD44 mRNA level was not significantly affected
by the addition of OP-1 to HA6 cultures. These mRNA
levels were all normalized by GAPDH competitive RT-PCR
analysis.
THE EFFECT OF OP-1 ON PROTEOGLYCAN BIOSYNTHESIS IN HA6
INDUCED MATRIX DEPLETION MODEL
While HA oligosaccharides have been shown to induce
chondrocytic chondrolysis, there is also concomitant induc-
tion of proteoglycan and HA biosynthesis11. However, in the
presence of the HA6, the newly synthesized proteoglycan
is not retained in the cell-associated matrix, because the
presence of the HA6 blocks the HA-binding activity of
CD44, resulting in a decrease of functional cell-associated
matrix38. To explore the effects of OP-1 on proteoglycan
synthesis in the HA6 matrix depletion model, HA6-treated
chondrocytes in the presence or absence of OP-1 were
pulse-labeled with 35S-sulfate in alginate bead cultures.
There was a significant increase in the total amount of PGs
synthesized with treatment of HA6 and OP-1 compared to
with HA6 alone (P=0.0048). In the cell-associated matrix,
the amount of newly synthesized PGs of cells treated with
OP-1 and HA6 treatment was significantly higher than that
in HA6 treatment alone (P=0.003). Interestingly, newly
synthesized PG in the cell-associated matrix depleted
by HA6 returned to control level with the addition of OP-1
(Fig. 2A). The effect of OP-1 on proteoglycan synthesis is
dose-dependent and the distribution of the newly syn-
thesized PG is prominent in the cell-associated matrix
(Fig. 2B). In the further-removed matrix and medium there
was not a significant difference in newly synthesized PGs
between control and treated chondrocytes. However, in the
cell-associated matrix fraction, treatment of chondrocytes
with 50 and 100 ng/ml of OP-1 together with HA6 signifi-
cantly stimulated the synthesis of PGs as compared to HA6
alone P=0.0016 and P=0.0006, respectively). No signifi-
cant differences were observed in chondrocytes treated
with HA6 and 10 ng of OP-1 (P=0.87).
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Fig. 1. The effect of OP-1 on CD44, HAS-2, aggrecan mRNA
expression by human articular chondrocytes treated with HA6.
Aliquots of total RNA derived from human articular chondrocytes
cultures treated by 250 µg/ml of HA6 with or without 100 ng/ml of
OP-1 for 5 days, were reverse transcribed and PCR amplified for
23 cycles in the presence of internal DNA standards for CD44 (4.0,
2.0, 1.0 and 0.5 attomoles of mimic), HAS-2 (30.0, 15.0, 7.5 and
3.75 attomoles of mimic) or, aggrecan (0.2, 0.1, 0.05 and 0.025
femtomoles of mimic). The products were separated on 1.5%
agarose gel and visualized by SYBR green I staining. Panel A,
lanes 1-4 show RNA derived from representative 5-day HA6
plus OP-1 treated cultures; lanes 5-8 show RNA derived from
5-day HA6 treated cultures. Lanes Sd represent 603-bp and
310-bp ϕX174/Hae III DNA marker bands. CD44 target 587 bp and
mimic 379 bp; HAS-2 target 409 bp and mimic 523 bp; aggrecan
target 620 bp and mimic 512 bp. In panel B, after normalization
with competitive RT-PCR using GAPDH RNA mimic, the ratio of
mRNA copy numbers, of cultures derived from OP-1 plus HA6
and control cultures (black bars), or HA6 and control cultures (light
gray bars) were plotted for each molecule. Data represent the
mean±standard deviation of triplicate experiments.
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THE EFFECT OF OP-1 ON CHONDROCYTE CULTURES IN HA6
INDUCED MATRIX DEPLETION MODEL
Isolated human articular chondrocytes cultured in
alginate beads assembled an alcian blue-positive matrix
(Fig. 3A). The staining for proteoglycan was enhanced by
treatment with OP-1 (Fig. 3B). After incubation for 7 days in
the presence of HA6, the alginate beads cultures showed
a substantial decrease in alcian blue staining for PGs
(Fig. 3C). However, when the chondrocyte cultures were
co-treated with OP-1 and HA6, the alcian blue positive
staining was again prominent, even somewhat enhanced
above the control level (Fig. 3D). This intense alcian
blue staining in the cell-associated region is in accord-
ance with the stimulated proteoglycan synthesis in the
cell-associated matrix pool (Fig. 2).
In the presence of calcium chelators the alginate gel
depolymerizes and the chondrocytes can be collected as
single cells. In this manner, following centrifugation of the
single-cell suspension to attach the chondrocytes to a
culture plastic substratum, the retained cell-associated
matrix can be visualized on living cells using a particle
exclusion assay. As shown in Fig. 4A, control chondrocytes
grown for 7 days in the presence of FBS all exhibited a
prominent cell-associated matrix – a matrix whose size can
be substantially enhanced by treatment with OP-1 (Fig. 4B,
4E) as previously reported25. In HA6 treated chondrocytes,
the cell-associated matrix size was nearly absent from
around the cells (Fig. 4C) resulting in a matrix area-to-cell
area equal to 0.2 following morphometric analysis (Fig. 4E).
However, co-treatment of chondrocytes with OP-1 in the
presence of HA6 prevented the reduction in cell-associated
matrix size observed in HA6 matrix depleted model
(Fig. 4D). The morphometric ratio under these conditions
was similar to that of control chondocytes (Fig. 4E).
THE EFFECT OF OP-1 ON CARTILAGE MATRIX RECOVERY IN HA6
INDUCED MATRIX DEPLETION MODEL
Slices of human articular cartilage isolated directly from
dissection were cultured in the presence of HA6 with or
without OP-1. Treatment of human articular cartilage with
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Fig. 2. The effect of OP-1 on PG synthesis and cellular distribution
in cultures of human articular chondrocytes treated with HA6.
Panel A, five days after the initial addition of HA6 or HA6 plus
OP-1, the cultures were pulse-labeled with 35S-sulfate for 4 h and
chased for an additional 24 h. The medium (white bars), further-
removed matrix (light gray bars) and cell-associated matrix (black
bars) pools were collected, and the specific incorporation of
35S-sulfate into PGs was determined using a rapid filtration
method. The level of 35S-sulfate labeled PGs synthesized was
normalized to cellular DNA content. Values represent the
average±SD of triplicate experiments; P=0.0048 for difference
between OP-1 plus HA6 and HA6 treatment bars in total amount,
P=0.003 between OP-1 plus HA6 and HA6 only treatment bars in
cell-associated matrix. Panel B depicts the dose-dependent effects
of OP-1 (10, 50 or 100 ng/ml) on 35S-sulfate incorporation for HA6
treated chondrocyte cultures.
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Fig. 3. Alcian blue staining of alginate bead chondrocyte cultures.
Panel A, control untreated human articular chondrocytes cultured
in alginate beads show a moderate alcian-blue positive matrix.
Panel B, 100 ng/ml of OP-1 treated human articular chondrocytes
show a prominent increased alcian-blue positive matrix. Panel C,
human articular chondrocytes cultured in alginate beads in the
presence of 250 µg/ml HA6 show an overall decrease in alcian-
blue positive matrix. Panel D, HA6 treated human articular
chondrocytes in the presence of OP-1 show a recovered alcian-
blue positive matrix compared to the chondrocytes treated with
HA6 only.
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250 µg/ml of HA6 for 14 days resulted in the prominent loss
of Safranin O positive matrix (Fig. 5A). However, 100 ng/ml
of OP-1 protected the cartilage from loss of PG due to HA6
induced matrix-depletion (Fig. 5B). HA plays an important
role to maintain the cell-associated matrix in articular carti-
lage, giving a scaffold to aggrecan, making proteoglycan
aggregates and binding chondrocytes via cell surface
receptor, CD44. HA accumulation in the cartilage matrix
was further analyzed using a specific biotinylated HABP
probe for HA. Staining for HA in normal untreated cartilage
is shown in the inset of Fig. 5C – staining that was almost
totally lost upon treatment with HA6 (Fig. 5C and 5E).
Addition of OP-1 in the HA6 induced matrix depletion model
stimulated HA accumulation, both in the superficial/upper
layer (Fig. 5D) and in deeper layers of articular cartilage
(Fig. 5F).
Discussion
Among the many changes that characterize cartilage
degeneration, one of the most dramatic events is the loss
of proteoglycans, especially aggrecan, from the extra-
cellular matrix. Loss of PG may be due to increased
PG degradation via elevated matrix metalloproteinase
activity39, inhibition of PG synthesis35,39,40, and inhibition
of PG retention due to changes in HA metabolism7. Our
previous work demonstrated that treatment of chondro-
cytes in cell culture with HA6 results in displacement of
the proteoglycan-rich cell-associated matrix, presumably
by uncoupling the interactions of HA with its principal
receptor, CD448,9. Treatment of cartilage explants with
HA6 caused a dramatic loss of proteoglycan in cartilage
extracellular matrix and induced chondrocytic chondro-
lysis, including activation of gelatinolytic and aggrecanase
activity. HA6 also induced an increase of proteoglycan
synthesis, including elevation of aggrecan and HAS-2
mRNA. However, this increase does not result in the
increase of functional cell-associated matrix11. This find-
ing suggests that successful repair in human cartilage
requires not only appropriate increased synthesis of
matrix molecules but also the components necessary to
retain and assemble the matrix constituents.
In the current study, OP-1 facilitated the recovery of a
cell-associated matrix in cultures of human chondrocytes or
cartilage explants that was disrupted by treatment with
HA6. In the short term, continued exposure of the cells to
high concentrations of HA6 would prevent retention of
newly synthesized HA or aggrecan. However, after 7 days
of incubation there is little HA6 remaining to effect direct
displacement from the CD44. The lack of matrix retention in
the HA6-treated cultures is likely due to the continuation of
induced catabolic cascade events. For example, in adult
bovine cartilage slices treated with HA6, chondrocytic
chondrolysis events continue even when the HA oligo-
saccharides are washed out of the tissues. Thus, it is likely
that the presence of OP-1 together with HA6 acts to
prevent or inhibit the signaling events that initiate the
degradative process. In previous studies we demonstrated
that treatment of chondrocytes or cartilage slices with IL-1
also resulted in the activation of a catabolic-like cascade
including the loss of cell-associated matrices surrounding
individual cells. All of these events occurred even though
the levels of CD44 and HAS-2 were elevated27,41. We
speculated that the increased CD44 was functional but now
being used for HA endocytosis rather than matrix retention.
The opposite results were obtained when CD44 expression
was upregulated by the treatment of chondrocytes with
OP-125,26. In this case the increased CD44 appeared to
contribute to enhanced cell-associated matrix retention.
Thus in this study, when OP-1 and HA6 are added together,
the intracellular mechanisms that regulate CD44 function
may now be shifted toward matrix retention as opposed to
HA internalization, resulting in enhanced HA and aggrecan
retention. This may explain why addition of OP-1 to
chondrocytes co-treated with HA6 resulted in enhanced
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Fig. 4. The effect of OP-1 on the cell-associated matrix of human
articular chondrocytes treated with HA6. Human articular chondro-
cytes were cultured in alginate beads in the presence of 5% FBS
for 7 days, released from alginate and transferred into 6-well
culture plates. Fixed erythrocytes were applied to the plated
chondrocytes to visualize the cell-associated matrix. Panel A,
control untreated chondrocytes; Panel B, chondrocytes treated
with 100 ng/ml of OP-1; Panel C, chondrocytes treated with
250 µg/ml of HA6 and, Panel D, chondrocytes treated with OP-1 in
the presence of HA6. Panel E depicts a morphometric analysis of
(matrix area-cell area)/cell area for each of the conditions shown in
panels A-D. Bars represent the mean±standard deviation of 10
cells per condition. Calculation of P-values demonstrated signifi-
cant differences (2-tailed student’s t-test) between control and
HA6=0.026 and; between HA6 and (HA6+OP-1)=0.002.
Differences between OP-1 and (HA6+OP-1)=0.124 and; between
control and (HA6+OP-1)=0.638 were not significant.
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35S-sulfate labeled proteoglycan accumulation and reten-
tion in the cell-associated matrix in addition to enhanced
overall biosynthesis.
Other studies have demonstrated that OP-1 can also
abrogate IL-1-induced suppression of 35S-sulfate labeled
proteoglycan synthesis42. This study examined the poten-
tial of OP-1 to module proteoglycan synthesis, but did not
examine other extracellular molecules, such as HA. In the
current study, not only were aggrecan, HAS-2 and CD44
mRNA upregulated, there was also a metabolic change that
made the chondrocytes ‘permissive’ and capable of utilizing
these components to assemble the functional HA-rich
cell-associated matrix. This permissive environment
may be due to inhibition of endogenous proteolytic activity,
A B
C D
E F
500 Pm
500 Pm
Fig. 5. The effect of OP-1 on PG or HA accumulation by human articular cartilage slices treated with HA6. Human articular cartilage slices
were treated without (A, C, E) or with (B, D, F) 100 ng/ml of OP-1 in the presence of 250 µg/ml of HA6 for 14 days. Cartilage slices were
stained with Safranin-O/fast green for PGs (A, B), or with biotinylated HABP probe for HA (C-F). Panels C, D depict the superficial/upper
layers of cartilage and; panels E, F the deeper layers of cartilage. Untreated control cartilage stained with the HABP probe is shown in the
inset of C. Arrows indicate superficial layer of the cartilage in panels A and B. The superficial surface is to the top in panels C-F.
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inhibition of oxygen radical release or, changes in
cytoskeletal-CD44 interactions that inhibit HA endocytosis
yet retain extracellular HA binding. In summary, in the HA6
model, wherein there is cartilage matrix depletion but no
inhibition of aggrecan biosynthesis (unlike the IL-1 model)
functional matrix retention still does not occur unless
agents such as OP-1 are present. Thus, attempts to
facilitate enhanced matrix biosynthesis may be of less
importance than altering the ‘permissive’ retention capacity
of chondrocytes such as occurs in the presence of OP-1.
This may explain why phases of attempted repair as seen
during the early stages of osteoarthritis inevitably fail.
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